Effects of Adjunctive Lacosamide on Mood States and Quality of Life (QOL) in Patients With Epilepsy

Completed

Conditions studied: Epilepsy

In brief

The purpose of this study is to determine the effect of lacosamide on mood and quality of life in people with epilepsy.

Key facts

Study ID

NCT01296880

Run by

State University of New York - Downstate Medical Center

People needed

60

Starts

2011-06-01

Expected to finish

2014-07-01

Last updated by the study team

2015-12-24

Who can join

Age: 17 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• At least 17 years old
• Have partial (focal) onset seizures that are not controlled with medication
• (LCM group only) LCM is being added to anti-epileptic drug regimen by treating physician

You may not qualify if…

• Have taken LCM in the past.
• Change in anti-epileptic drugs or their doses in the past 28 days.
• Have participated in another drug research study in the past 3 months.
• Have had epilepsy brain surgery, or plan to have epilepsy surgery in the next four months.
• Have a psychiatric or behavioral condition, which in the opinion of the investigator, could compromise patient's ability to participate in the study.
• Have a progressive (worsening) disease that affects patients brain and its functions.

Where it is running

• SUNY Downstate Medical Center — Brooklyn, New York, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.